1 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
βGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
15PubMed Papers
17Diseases
0Drugs
0Pathogenic Variants
DATA QUALITYβ Experimental GO Evidenceβ Swiss-Prot Reviewed
defense response to bacteriumprotein bindingdefense response to Gram-positive bacteriumextracellular regionmale reproductive organ cancerSplenomegalyAbruptio Placentaeuterine fibroid
Based on limited published evidence, LYG2 encodes a potent antibacterial protein involved in innate immunity. UniProt annotations indicate lysozyme activity and role in defense responses to bacteria, particularly Gram-positive bacteria, with localization to the extracellular region. LYG2 possesses protein-binding capacity. In chicken intestinal studies, LYG2 expression in the jejunum correlated significantly with Muricomes bacterial abundance during different egg-laying stages, suggesting potential interaction between host immune gene expression and intestinal microbiota composition 1.
1
LYG2 expression in chicken jejunum correlates with Muricomes bacterial abundance across egg-laying stages
PMID: 38891577β Limited data available β This gene has 1 indexed publication. Summary and analysis may be incomplete.
male reproductive organ cancerOpen Targets
Abruptio PlacentaeOpen Targets
uterine fibroidOpen Targets
Alzheimer diseaseOpen Targets
corneal ulcerOpen Targets
mucous membrane pemphigoidOpen Targets
osteoporosis-pseudoglioma syndromeOpen Targets
bacterial diseaseOpen Targets
familial hyperaldosteronismOpen Targets
cervical cancerOpen Targets
esophageal cancerOpen Targets
ovarian serous cystadenocarcinomaOpen Targets
uterine corpus endometrial carcinomaOpen Targets
No pathogenic variants reported on ClinVar for this gene.